Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;
|
|
- Clyde Bates
- 5 years ago
- Views:
Transcription
1
2 1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment it ensures that Nottingham University Hospital (NUH) researchers are able to undertake the proposed research study in accordance with the requirements of the study protocol and achieve recruitment to time and target. Applicable to all non-adopted non commercial studies requesting NUH NHS permission where the study originates within NUH, or where NUH is participating site at R&I team s discretion. 3. PROCESS R&I are notified of investigators intent to undertake a research study within NUH or documents are submitted to the R&I applications central box. Whichever is the earliest notification the allocated governance individual will undertake a feasibility assessment (FA) in conjunction with the research team. When a study is submitted to the R&I department the Research Administrative team will register the project, make up a file and add to DOCUMAS within 3 days. The R&I Operations Manager (or delegated individual) will then assign the study to a relevant member of the team for an initial review and confirmation on whether it is a valid submission. The allocated Research Manager/Research Governance Facilitator will determine which documents are missing by completing a checklist of missing documents (Appendix 1) which will be passed on to the Research Administrative team to send out to the individual who submitted the study within 6 days. Where NUH is requested to act as research sponsor organisation or as a participating site in a study the relevant feasibility assessment will be carried out using the RSS and NUH assessment tools in Appendix 2, a meeting/teleconference will be set up with the research team. The planning tool will quickly highlight any areas of concern. The reviewer can assess whether the Investigator and research team have the experience and capacity to carry out the study and assess the overall feasibility of the study with regards to resources, support department involvement and delivery of recruitment to time and target. The identification of any concerns at this stage means that they can be addressed promptly with the sponsor/ci/local investigator and appropriate plans can be put in place early in the NHS Permission process. Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is; SOP 49 Feasibility Assessments Non Commercial Studies Page 2
3 Feasible no further action required- proceed to governance review Potentially feasible areas to be addressed/resolved Not feasible at this time- R&I staff will discuss with the Investigator/Study team and Sponsor NUH R&I will work closely with the Investigator/study team and sponsor to resolve any issues. As soon as the outstanding study documents, as requested on the R&I submission checklist are received the application is considered to be a valid submission and the governance review may be undertaken taking into account the FA. The reviewer advises the PI/designated study contact of any governance queries for their action and documents these issues on the R&I governance review document and research database. The timeline from a valid submission being received to R&I approval time is aimed to be 30 calendar days. Please refer to Appendix 4 for a summary of the process. Once all the governance issues have been resolved the study may proceed to NHS permission. Post permission the study team are requested to report 1st patient recruited and quarterly reports (via address rdmon@nuh.nhs.uk)so recruitment to time and target can be monitored. SOP REVIEW PERIOD This procedure will be reviewed by the owner on a bi-annual basis, unless new local, national and/or international recommendations force an earlier review. SOP 49 Feasibility Assessments Non Commercial Studies Page 3
4 Appendix 1 Research & Innovation Application Checklist You must provide ALL documents that apply to your study before R&I will consider this a valid submission. R&I will notify you when your submission is considered to be valid Document Electronic copies (pdf format) of IRAS application including R&D and Site Specific Information (SSI) forms. Printed copy of SSI form with Declaration signed by PI or local collaborator including all authorisations ( ) from the support departments, e.g.pharmacy, Pathology Favourable opinion letter (pdf format) listing all approved documents (including amendments if applicable) from recognised REC/University of Nottingham Medical School Ethics Committee when available. Electronic copies of the following documents must have version number and date on each page and on appropriately headed paper: Protocol Participant Information Sheet Consent Form Other study documents (e.g. questionnaire, data collection forms) Electronic or hard copy of CV signed and dated (signed in last year) for each member of the research team Electronic or hard copy of ICH GCP training certificate (undertaken in last 2 years) for each member of the research team Clinical Trials Authorisation (CTA) from the Medicinal and Healthcare Products Regulatory Agency (MHRA) for CTIMPS or notice of no objection for medicinal devices, plus evidence of response to remarks and subsequent acceptance by MHRA. If your study involves imaging, the following documents must be sent by to MPE@nuh.nhs.uk and authorisations received: - Protocol - R&D & SSI form - Patient information sheet and consent form - Study Image summary sheet Please contact R&I at the earliest opportunity to discuss this. Human Tissue Transfer Agreement (HTTA) to be provided by the Sponsor (this may form part of agreement)- if required Clinical Trial Agreement (ABPI, unsigned) and costings proforma (on standard industry template) Indemnity (in ABPI format) and insurance certificate If pharmacy involvement; Pharmacy manual Drug preparation guidelines Drug storage requirements Comments (please explain why this document is not required) SOP 49 Feasibility Assessments Non Commercial Studies Page 4
5 Expiry details Label example Handling precautions. Please submit all electronic documents to SOP 49 Feasibility Assessments Non Commercial Studies Page 5
6 Appendix 2 Feasibility Assessment Study title: Principal Investigator: Contact information: Sponsor: Proposed start date: Adopted/non-adopted: Protocol Protocol 1) Is there anything in the protocol which is nonstandard and requires early support department discussions? N.B.: Radiology procedures- find out how many scans required & frequency & the number of patients. If a lot of patients or several scans required within a very narrow timeline, please flag this as an issue to the site to discuss with Radiology as soon as possible Funding 1) Has the project got funding- if no how are costs to be covered? 2) How much 3) Who from 4) Awarded or pending 5) NIHR partner? If NUH sponsoring then fees applicable N.B If project has no funding then cannot go ahead- (suggest applying for pump priming) Resource 1) Who will be working on the study? 2) Is there a back-up co-investigator? 3) Who will be taking consent? 4) Do site staff have sufficient resource? 5) How many studies are currently being run by the department? 6) Are there any competing studies? SOP 49 Feasibility Assessments Non Commercial Studies Page 6
7 Facilities Site: 1) Patient visits: - Who will do what? - Where will patients be seen (different departments)? - Will patients need to be sedated at any point (e.g. colonoscopies)? 2) Does the site have adequate facilities & equipment to accommodate the study? - Patient/research area - Blood pressure machine - ECG - Freezer - Fridge - Centrifuge - Water bath 3) If not, how will the site access facilities/equipment? Pharmacy: please ensure pharmacy are visited at the SSV by the Sponsor so that any concerns can be raised early 1) Which Pharmacy will be used? 2) Does Pharmacy have adequate storage facilities for the IMP? 3) Do they have the capacity? 4) Is there anything unusual about this drug/drug regime? 5) Will Pharmacy have to source drugs or are these provided by Sponsor? 6) Will these drugs be paid for by the Sponsor? 7) Chemo drugs- infusion devices- PVC infusion bags- which make? (Macopharma model not approved by NUH) SOP 49 Feasibility Assessments Non Commercial Studies Page 7
8 Other support departments: 1) Which support departments will be required to conduct the study? Recruitment 1) What will the primary recruitment methods be? a) Nurse/doctor approaching patient b) Database c) Posters d) Radio ads/newspaper ads 2) Who will be responsible for identifying patients? If a research nurse, check they are involved in the patient s clinical care- if they are not, they cannot search patient database/notes until consent is signed by the patient 3) Who will be responsible for driving recruitment? 4) What is the patient pathway? 5) Do other departments/people need to be contacted to make them aware of the study (think of the patient pathway)? Who will do this? 6) Is there anything in the protocol design or inclusion/exclusion criteria which may impact recruitment? 7) How many patients are currently seen a) Per month b) Per year 8) What is the anticipated screen failure rate? 9) Length of recruitment 10) Proposed recruitment target N.B Discuss with the site the importance of being recruitment ready. Provided staff are SOP 49 Feasibility Assessments Non Commercial Studies Page 8
9 involved in the clinical care of the patient the nurse/doctor can take some time prior to R&I approval to identify a list of potential patients, check inclusion/exclusion criteria. As soon as R&I approval has been granted, the patients can then be approached. Need to aim for FSI within 14-28days of R&I approval. Governance 1) Has everyone got an up-to-date CV and GCP training certificate? 2) Who will be completing the SSI form? Do they have an IRAS account? 3) Who will be responsible for submitting information to the support departments identified above? Are they aware of the new process ( authorisations)? 4) Who will submit all the documents to R&I? Aware of the process and requirements? General Site file: 1) Who will be responsible for ensuring site file is kept inspection-ready? 2) Where are files and study related documents stored? 3) Any issues with space identified? Medical Equipment: 1) Will any equipment be required for the purposes of the trial? Discuss the MESU procedure. Comments NUH feasibility assessment version Feb11 SOP 49 Feasibility Assessments Non Commercial Studies Page 9
10 Appendix 3 Dear Dr XXXX, Study title: R&I reference PI Sponsor Thank you for your time at the recent feasibility meeting/discussion At the meeting we discussed several items and I completed the NUH feasibility assessment for your site. i. Feasible no further action required- proceed to governance review ii. Potentially feasible areas to be addressed/resolved iii. Not feasible at this time All discussions have been documented in your feasibility assessment document and a copy is filed in the R&I department. At the visit I was asked to provide x and y on your behalf. These actions have now been completed. Or, the following actions are outstanding and list. Critical to the successful delivery of research studies at NUH is fast approval times and recruitment to target. NUH s target is to achieve first patient in within days of R&D approval/site initiation and we must endeavour to meet our agreed overall recruitment target. For non-nihr-adopted studies, please ensure that when you recruit your first patient, you contact rdmon@nuh.nhs.uk in R&I to alert us of the date. Thereafter, please ensure that you provide recruitment figures quarterly as these figures will now be reported to the Trust Board. If I can be of any further assistance please do not hesitate to contact me. SOP 49 Feasibility Assessments Non Commercial Studies Page 10
11 Appendix 4 R&I Process Flow Chart- Start to Approval Application comes into R&I via post / rdappl in box. 3 Days ADMIN-; 1) Make up file (inc KPI sheet in hard copy and in elec file) 2) Register on EPS and allocate R&I ref number 3) Add to non adopted tracker in R&I ref number in red & put file on review shelf CD checks non portfolio tracker daily. Allocates newly added studies to GOVN STAFF 3 Days GOVN STAFF- Initial check Generate checklist of missing documents/ confirms valid submission. GOVN STAFF- Arrange feasibility assessment with research team Assessment completed and outcome fed back to team Checklist of missing docs or confirmation of valid submission to ADMIN 2 Days ADMIN- send out missing docs list (standard 2a) with allocated R&I ref No. or confirmation of valid submission (standard 2b ) with allocated R&I ref No. Update non adopted tracker comment; If valid submission- turn R&I ref number green If further docs requested turn R&I ref number yellow. VALID SUBMISSION SOP 49 Feasibility Assessments Non Commercial Studies Page 11
12 GOVN STAFF GOVERNANCE REVIEW; (taking account of feasibility) 1) CTA and budget, costing proforma 2) REC favorable opinion 3) CTA from MHRA (if applicable) 4) Insurance cert 5) Localised docs 6) Signed and dated CVs (& GCP if CTIMP) Once CTA and Budget agreed with sponsor send to Amy. GREEN on contract tracker=ok GOVN STAFF Send outcome of governance review template to PI/study team. Keep PI/study team up to date with any progress or delays. Update non portfolio tracker comments. Ready for NHS permission GOVN STAFF Complete approval checklist- File to ADMIN for approval letter; FILE to Rachael for final checks. DOCUMAS, Archiving, Inclusion in project approved numbers. NHS permission letter not ready to go out Return file back to Reviewer SOP 49 Feasibility Assessments Non Commercial Studies Page 12
13 Within 30 Days ADMIN produce NHS permissions letter and obtain signature. Update DOCUMAS if letter being issued. R&I process flow chart v3 inc feasibility 24/07/11 CD SOP 49 Feasibility Assessments Non Commercial Studies Page 13
STANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number End of Study Report SOP-RES-027 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Natalie
More informationTrial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs
R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationSTANDARD OPERATING PROCEDURE SOP 325
STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author
More informationSOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227
SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationSOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup
SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationMHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager
MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection
More informationGaining NHS Trust R&D Approvals
Version 1.1 Effective date: 1 October 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Reason for change Version 1.1 1 October 2012
More informationResearch Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004
Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)
More informationSTANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice
STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role
More informationQuality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D
Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationThis Agreement dated DD/MM/YYYY (the Effective Date ) is between
Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or
More informationJoint R&D Support Office SOP S-2011 UHL
UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES Joint R&D Support Office SOP S-2011 UHL Site Initiation for
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July
More informationRD SOP12 Research Passport Honorary Contracts / Letters of Access
RD SOP12 Research Passport Honorary Contracts / Letters of Access Version Number: V2.1 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive
More information1. INTRODUCTION 2. SCOPE 3. PROCESS
1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationNational Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CCRN Portal for the latest version. Version: 5.2 Status: Consultation in
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Risk Assessment SOP-RES-002 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s)
More informationResearch Staff Training
REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision
More informationSetting up a Clinical Trial
York Foundation Trust R&D Unit SOP Pharm/S45 Setting up a Clinical Trial IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING USED All staff should regularly check
More informationR. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: BH/QMUL Sponsorship of CTIMPs, ATMPs and Clinical Trials of non- CE marked Medicinal Devices Process for Researchers SOP Number: 11a Version Number: V1.0 Effective
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationCorporate. Research Governance Policy. Document Control Summary
Corporate Research Governance Policy Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:
More informationDocument Title: Investigator Site File. Document Number: 019
Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationStandard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research
Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/006 Version V1.1 07 Apr 2016 Document Author(s) Document
More informationSTH Researcher. Recording of research information in patient case notes
STANDARD OPERATING PROCEDURE STH Researcher Recording of research information in patient case notes SOP History None SOP Number A108 Created Research Department (AL) SUPERSEDED Final 1.3 Version 3.5 Date
More informationDocument Title: Study Data SOP (CRFs and Source Data)
Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationStandard Operating Procedure (SOP)
Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP
More informationCLINICAL RESEARCH POLICY
CLINICAL RESEARCH POLICY Approved by: Date of approval: Originator: Medical Director POLICY STATEMENT Good quality clinical research is important for furthering our understanding of the problems encountered
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Corrective and Preventative Action SOP-QMS-008 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s)
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationProgress Review. Launch Meeting 3 rd April 2014, Lucas House, Birmingham
Progress Review Launch Meeting 3 rd April 2014, Lucas House, Birmingham Who s involved? Grant - NIHR/MRC Efficacy and Mechanism Evaluation (EME) Programme - Approved 2 nd May 2013, Started 1 st Feb 2014
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationSTANDARD OPERATING PROCEDURE 24. Training Records
STANDARD OPERATING PROCEDURE 24 Version: 1.4 Issue Date: 07 February 2018 Effective Date: 21 February 2018 Review Due: 21 February 2020 Author: Jill Wood, QA Manager WCTU WCTU Reviewers: Sponsor Reviewers:
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally
More informationM. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance and Safety Reporting for Sponsored non-ctimps SOP Number: 26b Version 2.0 Number: Effective Date: 29th November 2015 Review Date: 3 rd December
More informationUnofficial copy not valid
Page 2 (9) CONTENTS 1. PURPOSE... 3 2. DEFINITIONS... 3 3. RESPONSIBILITY... 3 4. INVESTIGATOR SELECTION... 3 4.1 Identification of Investigator s... 3 4.2 Initial Contacts... 4 4.3 Distribution of Pre-Study
More informationRisk Assessment and Monitoring
Version 1.3 Effective date: 25 May 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.3 25 May 2012 Version 1.2 29 January 2010
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationResearch Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012
Research Policy Author: Caroline Mozley Owner: Sue Holden Publisher: Caroline Mozley Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012 Approved by: Executive Board Date approved:
More informationThe Principal Investigator Role
The Principal Investigator Role Jo Rodda Consultant in Old Age Psychiatry, NELFT North Thames CRN Dementia Specialty Lead What is a Principal Investigator? The person responsible for the conduct of a research
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationStorage and Archiving of Research Documents SOP 6
Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationSOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection
SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection Authorship Team: Jemma Hughes, Tina Morgan, for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical
More informationGovernance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise
Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Delegation of Responsibilities SOP Reference QUB-ADRE-005 Date prepared 23 June 2008 Number: Version
More informationPERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES
PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES Version Control Item 20 Items 22, 23 Item 27 Added item regarding responsibility of providers to submit successfully
More informationMonitoring Clinical Trials
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationTRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
More informationStandard Operating Procedures
Standard Operating Procedures 5.7 Site Initiation Version V1.0 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 30/09/2017 Review date 30/09/2019 DO NOT USE THIS SOP IN PRINTED FORM WITHOUT
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of
More informationJoint Statement on the Application of Good Clinical Practice to Training for Researchers
Joint Statement on the Application of Good Clinical Practice to Training for Researchers HRA, MHRA, Devolved Administrations for Northern Ireland, Scotland and Wales v1.1 12/10/17 Summary This joint statement
More informationInvestigator Site File Standard Operating Procedure (SOP)
Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse
More informationCOMPETENCY FRAMEWORK
COMPETENCY FRAMEWORK Theresa Ledger Lead Nurse Research and Development Clinical Research Facility Sheffield C:\Documents and Settings\Robertus\My Documents\Mariann\CRF\CRF Portfolio and Competency Template_DRAFT
More informationStandard Operating Procedure:
Standard Operating Procedure: Preparation and Submission of Annual Progress Reports for all Research Projects and Development Safety Update Reports SOP Number: SOP-QA-21 Version No: 1 Author: Date: 1-9-15
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible
More informationR&D Operational Capability Statement
Trust Board in public 27 September 2012 Agenda item: 2.5 R&D Operational Capability Statement For: Note and acceptance decision Summary: The R&D Operational Capability Statement (RDOCS) sets out an Organisation
More informationNHS Research Scotland Permissions Coordinating Centre
permissions NHS Research Scotland Permissions Coordinating Centre (NRS Permissions CC) Coordinating faster permissions for Scotland A guide to who we are and what we do nrs c c Foreword from Sir John Savill,
More informationGCP INSPECTION CHECKLIST
(This list is not all inclusive; item may be added &/or deleted as per the Study/Site/Sponsor/Lab) I. General. Name and address of the clinical trial site Tel. No. & e- mail:. Date of Inspection. Inspection
More informationMANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic
More informationNHS REC Applications
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationVersion Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13
CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More informationSOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH THE START UP PROCEDURE FOR RESEARCH STUDIES
More informationClinical Trial Readiness Checklist October 2014
The clinical trial readiness checklist is a tool which can help new and experienced researchers prepare for upcoming clinical studies. It is designed to be a quick reference to ensure that you have the
More informationGCP Training for Research Staff. Document Number: 005
GCP Training for Research Staff Document Number: 005 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationChecklist prior to recruiting first patient
Pre-Site selection Site Initiation Visit (SIV) What kind of questions should you ask How you should prepare for this visit Delegation logs Training logs ECRF/CRF Checklist prior to recruiting first patient
More informationNIHR Guideline B01 R&D Operational Capability Statement for Dorset HealthCare University NHS Foundation Trust
NIHR Guideline B01 R&D Operational Capability Statement for Dorset HealthCare University NHS Foundation Trust Version History Version number Valid from Valid to Date approved Approved by Updated by RDOCS
More informationSTANDARD OPERATING PROCEDURE SOP 220. Investigation of allegations of Research Fraud and Misconduct. NNUH UEA Joint Research Office
STANDARD OPERATING PROCEDURE SOP 220 Investigation of allegations of Research Fraud and Misconduct Version 1.4 Version date 27.02.2018 Effective date 2.03.2018 Number of pages 8 Review date February 2020
More informationResearch Adverse Event and Safety Reporting Procedures Outcome Statement: Title:
Title: Research Adverse Event and Safety Reporting Procedures Outcome Statement: Research Teams will be able to correctly identify and report Adverse Events and complete Annual Safety Reports for research
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationEuropean Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS
European Medicines Agency Inspections London, 23 July 2008 EMEA/INS/GCP/197215/2005 Procedure no.: INS/GCP/3/V ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS GCP
More informationABMU R&D Operational Framework
ABMU R&D Operational Framework 2017 ABMU R&D Operational Framework 1 R&D Operational Arrangements University Partnership As a University Health Board, ABMU has signed a Memorandum of Understanding (MOU)
More informationSTANDARD OPERATING PROCEDURE SOP 205
STANDARD OPERATING PROCEDURE SOP 205 Adverse Events: Identifying, Recording and Reporting for CTIMPs Sponsored by the Norfolk and Norwich University Hospital NHS Foundation Trust Version 2.3 Version date
More informationMarie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance processing for the JRMO SOP Number: 26c Version Number: V1 Effective Date: 5/8/16 Review Date: 5/8/17 Author: Reviewer: Reviewer: Authorisation:
More informationResearch & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff
Department Title of SOP Research & Development Case Report Form SOP SOP reference no: R&D GCP SOP 03 Authors: Current version number and date: J H Pacynko and J Illingworth Version 2, 01.02.18 Next review
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Maintaining Training Records SOP Number: 20 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date:
More informationSOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils
Title: Assessment of Study Feasibility Manual: RI MUHC Policies and Procedures Human Research SOPs Originating Dept/ Service: RI MUHC Division of Clinical Research SOP: New Revised Reviewed Effective Date:
More information